Archive for the ‘El-Hibri’ Category

Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2012

ROCKVILLE, Md.–(BUSINESS WIRE)–Jan. 30, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the fourth quarter and full year 2011 on Thursday, March 8, 2012, after market close.
Company management will host a conference call at 5:00 pm Eastern on March 8, 2012 to discuss the financial results for the [...]

February 3, 2012  Tags: , , , ,   Posted in: Chief executive officer, El-Hibri, Investors, Revenue, fuad  No Comments

Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference

ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]

June 1, 2011  Tags: , , , , ,   Posted in: Business, El-Hibri, Financial Performance, Healthcare Conference, Investors, fuad el-hibri  No Comments

Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference

Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of [...]

April 5, 2011  Tags: , , , ,   Posted in: Board of Directors, El-Hibri, Emergent BioSolutions, Healthcare Conference, fuad, fuad el-hibri  No Comments

CEO took roundabout path to Emergent

By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]

January 7, 2011  Tags: , , , , ,   Posted in: Biosolutions, Business, CEO, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, Research and development, Trubion Pharmaceuticals, Yale University, fuad, fuad el-hibri  No Comments

Emergent BioSolutions Presents Positive Data from Its TRU-016 Program at American Society of Hematology Meeting

ROCKVILLE, Md., Dec 06, 2010 (BUSINESS WIRE) –
Emergent BioSolutions Inc. (NYSE: EBS) today announced the presentation of positive data from a Phase I dose escalation study of TRU-016 (Protocol 16007) at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida. In an oral [...]

December 15, 2010  Tags: , , , , , , ,   Posted in: American Society of Hematology, El-Hibri, Emergent BioSolutions, Non-Hodgkin lymphoma, fuad el-hibri  No Comments

Fuad El-Hibri Recognized by Vilcek Foundation

The Vilcek Foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia.  The Foundation was established with the aim of raising public awareness around immigrants’ contributions to the sciences, arts, and culture in the United States.  The Foundation’s mission was inspired [...]

December 10, 2010  Tags: , , , , , , ,   Posted in: El-Hibri, El-Hibri Peace Education Prize, Emergent BioSolutions, Peace Education, fuad el-hibri  No Comments

Fuad El-Hibri and the International Biomedical Research Alliance

The International Biomedical Research Alliance (IBRA) is a philanthropic organization that is dedicated to the support of the NIH-Oxford-Cambridge Scholars Program, which strives to establish the highest standards of excellence in training biomedical researchers, advance groundbreaking biomedical research, enrich the pool of leaders in the field, and eliminate barriers which frustrate [...]

November 13, 2010  Tags: , , , , , ,   Posted in: Biosolutions, Biothrax, El-Hibri, Emergent BioSolutions, Research and development, fuad el-hibri  No Comments

Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize

August  17,  2010  — The El-Hibri Charitable Foundation announced today that prominent peace educator, nationally renowned columnist and accomplished author Colman McCarthy has been selected as the recipient of the  2010 El-Hibri Peace Education Prize. The Prize, which carries a [...]

August 23, 2010  Tags: , , , , , , ,   Posted in: CEO, El-Hibri, El-Hibri Peace Education Prize, Emergent BioSolutions, Peace Education, fuad el-hibri  No Comments

Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments

ROCKVILLE, MD, June 24, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) led by CEO Fuad El-Hibri,announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations.  The company’s international sales efforts have resulted in these sales [...]

July 7, 2010  Tags: , , , , ,   Posted in: Anthrax vaccines, Biothrax, El-Hibri, Emergent BioSolutions, Vaccine, fuad el-hibri  No Comments

Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young

Marie-José Daoud
Awarded the Ernst and Young prize for Entrepreneur of the year 2009 in the Technology category for the Greater Washington region last June, Fuad El-Hibri is the CEO of Emergent Biosolutions, an American company that supplies the anthrax vaccine to the American government. He is in line for the national E&Y 2009 prize, which [...]

December 17, 2009  Tags: , , , , ,   Posted in: Biosolutions, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, fuad el-hibri  No Comments